{{Rsnum
|rsid=8191992
|Gene=CHRM2
|Chromosome=7
|position=137016561
|Orientation=plus
|GMAF=0.4743
|Gene_s=CHRM2,LOC349160
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 30.8 | 50.8 | 18.5
| HCB | 0.0 | 27.3 | 72.7
| JPT | 0.0 | 24.4 | 75.6
| YRI | 77.2 | 21.1 | 1.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 27.3 | 72.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}No significant association was found between this CHRM2 gene SNP and diverse measures of cognitive ability in two population based cohorts - one Scottish aged over 50 years (N = 2,091) and the other English comprising non-demented elderly participants (N = 758)- nor in a family-based Australian adolescent sample (N = 1,537).{{PMID|19418213}}

{{PMID Auto
|PMID=18979273
|Title=Acetylcholine receptor M2 gene variants, heart rate recovery, and risk of cardiac death after an acute myocardial infarction
}}

{{PMID|17373692|OA=1
}} No evidence for association between 19 cholinergic genes and bipolar disorder.

{{PMID|17601350|OA=1
}} A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.

{{PMID|17996044|OA=1
}} Exploring the functional role of the CHRM2 gene in human cognition: results from a dense genotyping and brain expression study.

{{PMID|18634760|OA=1
}} Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes.

{{PMID|19211801|OA=1
}} Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}